首页> 外文期刊>American Journal of Physiology >Partial restoration of cAMP-stimulated CFTR chloride channel activity in DeltaF508 cells by deoxyspergualin.
【24h】

Partial restoration of cAMP-stimulated CFTR chloride channel activity in DeltaF508 cells by deoxyspergualin.

机译:脱氧精精可以部分恢复AMPF508细胞中cAMP刺激的CFTR氯化物通道活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Deletion of the codon encoding phenylalanine 508 (DeltaF508) is the most common mutation in cystic fibrosis (CF) and results in a trafficking defect. Mutant DeltaF508-CF transmembrane conductance regulator (CFTR) protein retains functional activity, but the nascent protein is recognized as abnormal and, in consequence, is retained in the endoplasmic reticulum (ER) and degraded. It has been proposed that this retention in the ER is mediated, at least in part, by the cellular chaperones heat shock protein (HSP) 70 and calnexin. We have investigated the ability of deoxyspergualin (DSG), a compound known to compete effectively for binding with HSP70 and HSP90, to promote trafficking of DeltaF508-CFTR to the cell membrane. We show that DSG treatment of immortalized human CF epithelial cells (DeltaF508) and cells expressing recombinant DeltaF508-CFTR partially restored cAMP-stimulated CFTR Cl- channel activity at the plasma membrane. Although there are several possible explanations for these results, one simple interpretation is that DSG may have altered the interaction between DeltaF508-CFTR and its associated chaperones. If this is correct, agents capable of altering the normal functioning of cellular chaperones may provide yet another means of restoring CFTR Cl- channel activity to CF subjects harboring this class of mutations.
机译:编码苯丙氨酸508(DeltaF508)的密码子的删除是囊性纤维化(CF)中最常见的突变,并导致运输缺陷。突变的DeltaF508-CF跨膜电导调节剂(CFTR)蛋白保留了功能活性,但是新生蛋白被认为是异常的,因此保留在内质网(ER)中并降解。已经提出,在ER中的这种保留至少部分地由细胞伴侣热激蛋白(HSP)70和钙联接蛋白介导。我们已经研究了脱氧精胰岛素(DSG)(一种已知能有效竞争与HSP70和HSP90结合的化合物)促进DeltaF508-CFTR向细胞膜运输的能力。我们显示永生化的人类CF上皮细胞(DeltaF508)和表达重组DeltaF508-CFTR的细胞的DSG治疗部分恢复了cAMP刺激的CFTR Cl-通道在质膜上的活性。尽管对于这些结果有几种可能的解释,但一种简单的解释是DSG可能已经改变了DeltaF508-CFTR及其相关伴侣分子之间的相互作用。如果这是正确的,则能够改变细胞伴侣的正常功能的药物可能会提供另一种方法,使具有此类突变的CF受试者恢复CFTR Cl通道的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号